This activity is intended for diabetologists & endocrinologists, primary care physicians, and cardiologists.
The goal of this activity is to highlight the importance of treating obesity as a disease.
Upon completion of this activity, participants will:
- Have increased knowledge regarding the
- Linkages between obesity and its associated comorbidities
- Treatment options for obesity management
- Have greater competence related to
Applying best practices in the assessment and treatment of obesity to reduce negative health outcomes from comorbidities
Accreditation and Credits
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Association of Clinical Endocrinologists AACE and Medscape. AACE is accredited by the ACCME to provide continuing medical education for physicians.
The American Association of Clinical Endocrinologists (AACE) designates this enduring material for a maximum of .5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is supported by an independent educational grant from Novo Nordisk Inc.